Literature DB >> 24912998

Prevalence of DRESS syndrome.

Eunice López-Rocha1, Lizbeth Blancas, Karen Rodríguez-Mireles, Arturo Gaspar-López, Patricia O'Farrill-Romanillos, Adela Amaya-Mejía, Lucy Galindo-Pacheco, Freya Campos-Romero, Nadia Aguilar-Hinojosa, Guadalupe Suárez.   

Abstract

DRESS syndrome (Drug rash with Eosinophilia and Systemic Symptoms) is an idiosyncratic reaction (type B), characterized by peripheral eosinophilia and systemic symptoms, such as fever, rash, lymphadenopathy, hepatitis, atypical lymphocytes and elevation of liver enzymes at least twice its normal level or increase of alanine amino transferase (ALT) >100 U/L. Its incidence is of 1/1,000 to 10,000 exposures and its mortality is of 10%-20%. Treatment is based on steroids and on the suspension of the suspect drug. This paper reports the cases of six patients with DRESS syndrome attended at Centro Medico Nacional Siglo XXI, Mexico City, from September 2012 to September 2013, which accounted for 12.5% of patients attended with adverse reactions to drugs.

Entities:  

Keywords:  DRESS syndrome; Drug-reactions; Eosinophilia; Exantema; Systemic symptoms

Mesh:

Substances:

Year:  2014        PMID: 24912998

Source DB:  PubMed          Journal:  Rev Alerg Mex        ISSN: 0002-5151


  2 in total

1.  Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome in a paediatric patient taking zonisamide.

Authors:  Ashifa Trivedi; Sadhna Sharma; Ranjith Govindan
Journal:  Eur J Hosp Pharm       Date:  2020-10-26

Review 2.  Current Perspectives on Severe Drug Eruption.

Authors:  Jingzhan Zhang; Zixian Lei; Chen Xu; Juan Zhao; Xiaojing Kang
Journal:  Clin Rev Allergy Immunol       Date:  2021-07-17       Impact factor: 8.667

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.